First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2012-05-31 18:41:59Open Document File Size: 242,58 KBShare Result on FacebookCompanySouthern Hospital Group / 3M / /CountryWales / / /EventFDA Phase / /FacilityWales Hospital / Cancer Institute NSW / Sydney Children’s Hospital / Royal Hospital / /IndustryTermintended insertion site / metal / soft wing devices / exit site / injection site / insertion site / symptom management / sub cut devices / Cancer Care / subcutaneous site / metal introducer / area subcutaneous line management / /MedicalConditionallergies / sudden rash / pneumothorax / erythema / needle stick injury / pain / lung disease / exanthema / Sharps Injuries / irritation / infection / inflammation / Pain relief/ needle phobia / /MedicalTreatmentcatheter / cannulas / pain management / cannula / /OrganizationDRAFT SESIAHS Palliative Care Working Party / Wales Hospital / DRAFT SESIAHS Area Drug Committee / POLICY STATEMENT Administration / Sydney Children’s Hospital / Royal Hospital for Women / Albion St Centre / University of Wisconsin / /PersonPrince / /PositionPrince / driver / Governor / REVISION AND APPROVAL HISTORY Date Revision No. Author / DRAFT Palliative Care Director / Director Meeting April / medical officer / pharmacist network specialist medicines / syringe driver / NSW Public Health System Nurse / regular Subcutaneous Medication EXECUTIVE CLINICAL SPONSOR Director Area Cancer Services AUTHOR / /ProductGuidelines PD2005_105 Methadone injection / Subcutaneous Medication / EMLA / Chlorhexidine Gluconate / SCH medication / B2 Subcutaneous medication / Area Drug / Revision / /ProvinceOrStateWisconsin / /URLhttp /SocialTag |